It’s Official: Perrigo’s Entirely Consumer Health
Executive Summary
"We are now a leading pure-play global consumer self-care company that has significant resources to invest,” says CEO Murray Kessler with Rx business sale closing.
You may also be interested in...
Long Promised, Self-Care Is ‘Real’ With Opportunity
Fred Hassan, a director with private equity firm Warburg Pincus and an OTC industry veteran, recalls when consumer health meant nonprescription drugs and when self-care was a concept, not a description for consumers’ health care choices.
Perrigo Debuts On US National Brand Stage With OTC Switch Approval For Nasonex 24HR Allergy
Nasonex 24HR Allergy also will be first OTC mometasone furoate product available in US. It will compete in OTC intranasal corticosteroids category already led by other brands switched from Rx to nonprescription over past eight years.
HBW Insight’s Key Takeaways From 2021: #1 Join The Self-Care Movement
The first year of the pandemic saw a move among consumers towards prevention and wellness under the banner of "self-care". In 2021, the "self-care movement" really started to gain momentum as these new healthcare habits endured, and companies responded with more wellness options, in some cases even pivoting towards becoming pure self-care players.